BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21501907)

  • 1. Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents.
    Tahghighi A; Marznaki FR; Kobarfard F; Dastmalchi S; Mojarrad JS; Razmi S; Ardestani SK; Emami S; Shafiee A; Foroumadi A
    Eur J Med Chem; 2011 Jun; 46(6):2602-8. PubMed ID: 21501907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.
    Tahghighi A; Emami S; Razmi S; Rezazade Marznaki F; Kabudanian Ardestani S; Dastmalchi S; Kobarfard F; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):843-52. PubMed ID: 22651800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties.
    Tahghighi A; Razmi S; Mahdavi M; Foroumadi P; Ardestani SK; Emami S; Kobarfard F; Dastmalchi S; Shafiee A; Foroumadi A
    Eur J Med Chem; 2012 Apr; 50():124-8. PubMed ID: 22336386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immunobiological studies of novel 5-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazoles with piperazinyl-linked benzamidine substituents against Leishmania major.
    Rezazadeh Marznaki F; Shakeri R; Kaboudanian Ardestani S; Tahghighi A; Foroumadi A
    Iran J Allergy Asthma Immunol; 2013 Aug; 12(4):368-76. PubMed ID: 23996713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.
    Behrouzi-Fardmoghadam M; Poorrajab F; Ardestani SK; Emami S; Shafiee A; Foroumadi A
    Bioorg Med Chem; 2008 Apr; 16(8):4509-15. PubMed ID: 18321711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives.
    Foroumadi A; Emami S; Pournourmohammadi S; Kharazmi A; Shafiee A
    Eur J Med Chem; 2005 Dec; 40(12):1346-50. PubMed ID: 16095763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.
    Trefzger OS; Barbosa NV; Scapolatempo RL; das Neves AR; Ortale MLFS; Carvalho DB; Honorato AM; Fragoso MR; Shuiguemoto CYK; Perdomo RT; Matos MFC; Chang MR; Arruda CCP; Baroni ACM
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900241. PubMed ID: 31840866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species.
    Poorrajab F; Ardestani SK; Foroumadi A; Emami S; Kariminia A; Behrouzi-Fardmoghadam M; Shafiee A
    Exp Parasitol; 2009 Apr; 121(4):323-30. PubMed ID: 19124020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles.
    Alipour E; Emami S; Yahya-Meymandi A; Nakhjiri M; Johari F; Ardestani SK; Poorrajab F; Hosseini M; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):123-8. PubMed ID: 20578974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action.
    Mojallal-Tabatabaei Z; Foroumadi P; Toolabi M; Goli F; Moghimi S; Kaboudanian-Ardestani S; Foroumadi A
    Bioorg Med Chem; 2019 Aug; 27(16):3682-3691. PubMed ID: 31300318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
    Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
    Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids.
    Baréa P; Barbosa VA; Bidóia DL; de Paula JC; Stefanello TF; da Costa WF; Nakamura CV; Sarragiotto MH
    Eur J Med Chem; 2018 Apr; 150():579-590. PubMed ID: 29549842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antileishmanial activity and structure-activity relationship of 1-N-X-phenyl-3-N'-Y-phenyl-benzamidines.
    Rodrigues-Santos CE; Leon LL; Bortoluzzi AJ; Canto-Cavalheiro MM; Machado GC; Echevarria A
    Eur J Med Chem; 2013 Sep; 67():166-74. PubMed ID: 23851118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents.
    Mayence A; Vanden Eynde JJ; LeCour L; Walker LA; Tekwani BL; Huang TL
    Eur J Med Chem; 2004 Jun; 39(6):547-53. PubMed ID: 15183913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
    Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
    Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azaterphenyl diamidines as antileishmanial agents.
    Hu L; Arafa RK; Ismail MA; Wenzler T; Brun R; Munde M; Wilson WD; Nzimiro S; Samyesudhas S; Werbovetz KA; Boykin DW
    Bioorg Med Chem Lett; 2008 Jan; 18(1):247-51. PubMed ID: 18006310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of novel 5-(5-amino-1-aryl-1H-pyrazol-4-yl)-1H-tetrazole derivatives against promastigotes and amastigotes of Leishmania amazonensis.
    dos Santos Faiões V; Leon LL; Canto-Cavalheiro MM; Torres-Santos EC; Bernardino AM; Vegi PF; dos Santos MS
    Chem Biol Drug Des; 2014 Mar; 83(3):272-7. PubMed ID: 24119090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
    Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
    Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
    Gontijo VS; Espuri PF; Alves RB; de Camargos LF; Santos FV; de Souza Judice WA; Marques MJ; Freitas RP
    Eur J Med Chem; 2015 Aug; 101():24-33. PubMed ID: 26112378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.